Miach Orthopaedics
Westborough, US · Founded 2016 · Delaware corporation · 83 employees on LinkedIn · 4 known investors
Find your way into Miach Orthopaedics
1,030 people in our graph share verified history with the Miach Orthopaedics team — schools, employers, funds. One of them is your warm intro.
Mike Volpiunlockedknows Martha Murray · together at Stanford University (overlapped)
knows the team · via University of Pennsylvania School of Medicine
×3knows the team · via Boston Children's Hospital
×4knows the team · via Stanford University
×2knows the team · via Harvard Medical School
knows the team · via United States Military Academy at West Point
Miach Orthopaedics develops implants that help the body restore its own connective tissue, with an initial focus on treating ACL tears. Its lead product is the BEAR Implant for bridge-enhanced ACL restoration, positioned in the orthopedic medical device field.
Founders & leadership
Miach Orthopaedics was founded in 2016 by Martha Murray.
MM
Martha MurrayinFounderMartha Murray is an orthopedic surgeon with expertise in clinical research, medical education, and biomechanics who founded Miach Orthopaedics, which develops implants for ACL restoration and connective tissue repair.
CJ
Chris JoyceinChief Financial Officer
PM
Patrick McBrayerinPresident & CEO2022–2026He brings more than 35 years of experience in orthopaedics and regenerative medicine, including prior leadership roles at ACell, AxioMed Spine Corporation, Exogen, Osteotech, and Xylos Corporation, as well as co-founder experience at Transave (now Insmed), and held positions at Johnson & Johnson early in his career. He is a graduate of the United States Military Academy at West Point.
SS
Sean SansiveriNamed on SEC filing
PW
Pieter WoltersNamed on SEC filing
Board
MM
Marc-Andre MarcotteBoard director
JE
FP
AM
Arpesh MehtaBoard director
MC
Matt CurtinBoard director
KI
Kristine IlariaBoard director
TP
Tom PattonBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$74.3M disclosed across 4 rounds · 2023–2026
▶$6.5MraisedMay 2026 · 14 investors · Other Health CareRule 506(b)
▶$6.5MraisedMay 2026 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matt CurtinDirector
- Tom PattonDirector
- Joyce EronyDirector
- Chris JoyceExecutive Officer
- Arpesh MehtaDirector
- Michael SjostromDirector
- Patrick McBrayerExecutive Officer, Director
- Andy RadfordDirector
- Fernando PachecoDirector
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedOct 2025 · 14 investors · Other Health CareRule 506(b)
▶$7.5MraisedOct 2025 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tom PattonDirector
- Marc-Andre MarcotteDirector
- Chris JoyceExecutive Officer
- Joyce EronyDirector
- Fernando PachecoDirector
- Patrick McBrayerExecutive Officer, Director
- Arpesh MehtaDirector
- Matt CurtinDirector
- Kristine IlariaDirector
- Offering amount
- $15M
- Amount sold
- $7.5M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedApr 2024 · 11 investors · Other Health CareRule 506(b)
▶$20MraisedApr 2024 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sean SansiveriDirector
- Kristine IlariaDirector
- Patrick McBrayerExecutive Officer, Director
- Pieter WoltersDirector
- Fernando PachecoDirector
- Marc-Andre MarcotteDirector
- Thomas PattonDirector
- Joyce EronyDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40.3MraisedFeb 2023 · 9 investors · Other Health CareRule 506(b)
▶$40.3MraisedFeb 2023 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sean SansiveriDirector
- Fernando PachecoDirector
- Marc-Andre MarcotteDirector
- Kristine IlariaDirector
- Patrick McBrayerExecutive Officer, Director
- Pieter WoltersDirector
- Christopher P. JoyceExecutive Officer
- Joyce EronyDirector
- Offering amount
- $40.3M
- Amount sold
- $40.3M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Miach Orthopaedics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Miach Orthopaedics do?
- Miach Orthopaedics develops implants that help the body restore its own connective tissue, with an initial focus on treating ACL tears. Its lead product is the BEAR Implant for bridge-enhanced ACL restoration, positioned in the orthopedic medical device field.
- Who founded Miach Orthopaedics?
- Miach Orthopaedics was founded by Martha Murray in 2016.
- Who are Miach Orthopaedics's investors?
- Miach Orthopaedics's investors include Amzak Health, APERTURE Venture Partners, Endeavour Vision, SV Health Investors.
- How much funding has Miach Orthopaedics raised?
- Miach Orthopaedics has disclosed $74.3M raised across 4 rounds.
- Where is Miach Orthopaedics headquartered?
- Miach Orthopaedics is headquartered in Westborough, US.